Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Al-Khatib

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
Journal of Travel Medicine|May 31, 2022
Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infectionsSuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
American Journal of Epidemiology|December 7, 2023
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study designHoussein H Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
Nature Medicine|November 3, 2021
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in QatarPatrick Tang, Mohammad R Hasan, Hiam Chemaitelly, et al.
The Lancet. Infectious Diseases|March 13, 2023
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort studyHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
The Lancet. Microbe|November 14, 2022
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Eclinicalmedicine|August 3, 2023
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studySuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2023
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyHiam Chemaitelly, Jeremy Samuel Faust, Harlan M Krumholz, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
Journal of Travel Medicine|May 31, 2022
Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infectionsSuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
American Journal of Epidemiology|December 7, 2023
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study designHoussein H Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
Nature Medicine|November 3, 2021
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in QatarPatrick Tang, Mohammad R Hasan, Hiam Chemaitelly, et al.
The Lancet. Infectious Diseases|March 13, 2023
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort studyHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
The Lancet. Microbe|November 14, 2022
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Eclinicalmedicine|August 3, 2023
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studySuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2023
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyHiam Chemaitelly, Jeremy Samuel Faust, Harlan M Krumholz, et al.
Pageof 15